Date | Time | Source | Headline | Symbol | Company |
07/01/2024 | 8:30AM | PR Newswire (US) | SILICOM'S SECOND QUARTER 2024 RESULTS RELEASE SCHEDULED FOR JULY 29, 2024 | NASDAQ:SILC | Silicom Ltd |
07/01/2024 | 8:30AM | PR Newswire (US) | Revolutionising Customer Engagement with Emotionally Intelligent Customisable AI Avatars | | |
07/01/2024 | 8:30AM | PR Newswire (US) | Roundhill Cannabis ETF (WEED) Waives Fees to 0.00% | AMEX:YBTC | Roundhill Bitcoin Covered Call Strategy ETF |
07/01/2024 | 8:30AM | PR Newswire (US) | U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes | NASDAQ:ICCM | IceCure Medical Ltd |
07/01/2024 | 8:30AM | PR Newswire (US) | Roundhill Cannabis ETF (WEED) Waives Fees to 0.00% | TSX:WEED | Canopy Growth Corporation |
07/01/2024 | 8:30AM | PR Newswire (US) | Anchin Expands Florida Footprint and Private Client Tax Team | | |
07/01/2024 | 8:30AM | PR Newswire (US) | Roundhill Cannabis ETF (WEED) Waives Fees to 0.00% | AMEX:QDTE | Roundhill N 100 0DTE Covered Call Strategy ETF |
07/01/2024 | 8:30AM | PR Newswire (US) | SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION | NASDAQ:SERA | Sera Prognostics Inc |
07/01/2024 | 8:30AM | PR Newswire (US) | Roundhill Cannabis ETF (WEED) Waives Fees to 0.00% | AMEX:XDTE | Roundhill S&P 500 0DTE Covered Call Strategy ETF |
07/01/2024 | 8:27AM | GlobeNewswire Inc. | Invesco Ltd: Form 8.3 - Quanex Building Products Corportation | | |
07/01/2024 | 8:27AM | PR Newswire (US) | Veteran Southern District Securities Prosecutor Kiersten Fletcher to Join Cahill's New York Office as a White Collar Defense and Investigations Partner | | |
07/01/2024 | 8:26AM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | USOTC:BMOLF | Bank of Montreal (PK) |
07/01/2024 | 8:25AM | GlobeNewswire Inc. | LightSolver Selected by Airbus and BMW Group as a Finalist in Quantum Computing Challenge | | |
07/01/2024 | 8:20AM | Business Wire | N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials | | |
07/01/2024 | 8:18AM | PR Newswire (US) | The Shared Dream, documentary co-produced by China and Kazakhstan, to air globally/ China, Kazakhstan co-produced film to mark SCO Summit 2024 | | |
07/01/2024 | 8:17AM | Business Wire | Berkshire Hathaway Specialty Insurance Expands to the Nordics, Names Regional and Product Line Leadership | | |
07/01/2024 | 8:17AM | PR Newswire (US) | Boohoo Doubles Down on Social Commerce with Thousands of Creator Storefronts | | |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Tims China Announces Significant Financing from Founding Shareholders | TSX:QSR | Restaurant Brands International Inc |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Tims China Announces Significant Financing from Founding Shareholders | NASDAQ:THCHW | TH International Limited |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Tims China Announces Significant Financing from Founding Shareholders | NYSE:QSR | Restaurant Brands International Inc |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Tims China Announces Significant Financing from Founding Shareholders | NASDAQ:THCH | TH International Limited |
07/01/2024 | 8:15AM | Alliance News | TOP NEWS: German yearly consumer price inflation rate eases to 2.2% | | |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer | TG:OFK | Orion Corporation |
07/01/2024 | 8:15AM | Business Wire | Ardian Raises $3.2 Billion for Sixth-Generation Co-Investment Platform | | |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Inside information: Orion upgrades full-year outlook for 2024 | BIT:1ORNBV | Orion Corporation |
07/01/2024 | 8:15AM | Business Wire | Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer | NYSE:MRK | Merck and Co Inc |
07/01/2024 | 8:15AM | Business Wire | Geneoscopy Files Counterclaims Against Exact Sciences | | |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Inside information: Orion upgrades full-year outlook for 2024 | TG:OFK | Orion Corporation |
07/01/2024 | 8:15AM | GlobeNewswire Inc. | Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer | BIT:1ORNBV | Orion Corporation |
07/01/2024 | 8:15AM | Business Wire | Relative Value Partners to Join Kovitz | | |